🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to find the highest tolerable d...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-12-17
Trial ID
NCT01891981
Treatments Being Tested
RATIONALE: The CAT-8015 immunotoxin can bind tumor cells and kill them with...
Status
Unknown
Location
Stanford University School of Medicine
Start Date
2007-04
Trial ID
NCT00462189
Treatments Being Tested
RATIONALE: The CAT-8015 immunotoxin can bind tumor cells and kill them with...
Status
Unknown
Location
Tower Hematology Oncology Medical Group
Start Date
2007-08
Trial ID
NCT00515892
A dose-escalation study to estimate the maximum tolerated dose(MTD) of CAT-...
Status
Terminated
Location
Tower Hematology Oncology Medical Group
Start Date
2007-08
Trial ID
NCT00587015
Treatments Being Tested
Although antibody-drug conjugate(ADC) has proved effective in treating many...
Status
Completed
Location
Central South University
Start Date
2022-04-22
Trial ID
NCT05349383
Background: \- Moxetumomab pasudotox is an experimental non-chemotherapy c...
Status
Completed
Location
Research Site
Start Date
2013-04-29
Trial ID
NCT01829711
Treatments Being Tested
Background: Hairy cell leukemia (HCL) is a rare, slow-growing blood cancer...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-10-03
Trial ID
NCT03805932
The primary objective of this study is to evaluate the efficacy of moxetumo...
Status
Terminated
Location
Research Site
Start Date
2014-08
Trial ID
NCT02227108
Treatments Being Tested
A dose-escalation study to estimate maximum cummulative dose (MTCD) of CAT-...
Status
Completed
Location
Research Site
Start Date
2008-09
Trial ID
NCT00659425
Treatments Being Tested
The primary objectives of this study are to determine the maximum tolerated...
Status
Completed
Location
Research Site
Start Date
2010-02-15
Trial ID
NCT01030536
Treatments Being Tested